Salomé Declerck

Mrs. Salomé Declerck

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
SDSalomé Declerck
Salomé Declerck
GHGuillaume Henin
Guillaume Henin
NLNicolas Lanthier
Nicolas Lanthier

4 September 2026 in Liver International
Verified
Journal Article
Closed access
GDGeraldine Dahlqvist
Geraldine Dahlqvist
SDSalomé Declerck
Salomé Declerck
MLMaxence Lepour
Maxence Lepour
ADAlicia Delorme
Alicia Delorme
ACAlix Collard
Alix Collard
NLNicolas Lanthier
Nicolas Lanthier

28 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SDSalomé Declerck
Salomé Declerck
GHGuillaume Henin
Guillaume Henin
SAStéphanie André-Dumont
Stéphanie André-Dumont
AGAnnette Gouw
Annette Gouw
CSChristine Sempoux
Christine Sempoux
NLNicolas Lanthier
Nicolas Lanthier
Background and aims: Lifestyle factors could influence the development of metabolic dysfunction–associated steatotic liver disease (MASLD). However, there is a lack of data including the consumption of ultra-processed foods (UPF) within the broad field of steatotic liver disease. Methods: Dietary intake and physical activity were assessed using standardized questionnaires in patients with MASLD, ALD and healthy controls. Liver disease severity was quantified by transient elastography and liver histology. Results: One hundred and fifty-two patients with MASLD were recruited and compared with 95 patients with ALD and 31 controls. Patients with MASLD consume significantly less total calories than patients with ALD (1620 vs. 2290 kcal/day, p < 0.0001), primarily due to lower alcohol intake, despite a higher body mass index. ALD patients consume lower proportions of proteins, lipids, carbohydrates, and dietary fibres than MASLD and control groups. Fibre intake is higher in the control group compared with the MASLD and ALD groups. In the biopsied MASLD subgroup, significant fibrosis is associated with a lower fibre intake (15 vs. 19 g/day, p = 0.03). No differences in NOVA category distribution are observed between MASLD and control groups, and UPF intake is not associated with liver histological severity. Controls devote a greater proportion of leisure-time physical activity (54% vs. 11% in MASLD and 17% in ALD, p < 0.0001). Conclusions: Patients with MASLD and ALD exhibit lower dietary fibre intake and reduced leisure-time physical activity compared with controls. Fibre intake, but not UPF consumption, is associated with fibrosis severity in MASLD.

12 October 2026 in Liver International
Verified
Journal Article
Closed access
PDF file
SDSalomé Declerck
Salomé Declerck
NLNicolas Lanthier
Nicolas Lanthier
GDGeraldine Dahlqvist
Geraldine Dahlqvist

5 November 2026 in Liver International
Verified
Journal Article
Closed access
SDSalomé Declerck
Salomé Declerck
NLNicolas Lanthier
Nicolas Lanthier
GDGeraldine Dahlqvist
Geraldine Dahlqvist